alexa A Randomized Controlled Trial Comparing Intramuscular Prostodin? And Intravaginal Misoprostol? Cervical Dilatation For Fi Rst Trimester Termination Of Pregnancy Or Missed Abortion | 7192
ISSN: 2161-0665

Pediatrics & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

A Randomized controlled trial comparing intramuscular prostodin? and intravaginal Misoprostol? cervical dilatation for fi rst trimester termination of pregnancy or missed abortion

International Conference on Pediatrics & Gynecology

Bansal Reena, Chandra and Subhash

Accepted Abstracts-2011: Pediatr Therapeut

DOI: 10.4172/2161-0665.S1.06

Context: Cervical priming using prostaglandins prior to surgical evacuation reduces the risks of cervical injury. Objective : To compare the effi cacy of intramuscular Prostodin and intravaginal Misoprostol in cervical dilatation for fi rst trimester termination of pregnancy or missed abortion. Design, Setting, and Participants: A randomized controlled trail was conducted between November 2008 to August 2010 at a tertiary care and academic hospital in Southern India. One hundred adult pregnant women up to 12 weeks of gestation, aged 18 to 35 years, opted for medical termination of pregnancy or presented with missed abortion. Fift y were randomized to receive intramuscular Prostodin and rest 50 intravaginal Misoprostol. Intervention: Aft er randomization to one or another group, patients received deep intramuscular injection of 1 ml Prostodin (equivalent of 250microgram of carboprost) or 600 microgram of Misoprostol intravaginally. Primary outcome measure: Amount of cervical dilatation achieved. Cervical dilatation was measured aft er 4 hours of drug administration using Hegar?s dilator. Results: Th ere was no signifi cant diff erence in distribution of age (p=0.832), parity (p=0.537), and proportion of missed abortion and elective medical termination of pregnancy (p=0.368), between two groups. Mean (standard deviation) cervical dilatation in Misoprostol group was signifi cant higher and protodin group, 9.2 (3.1) and 7.7 (2.1) cm, respectively (p=0.005). Th e mean diff erence (std. error) between two groups was 1.54 (0.53) cm. Mean (SD) amount of blood loss in Misoprostol group was 58.8 (20.1) ml which was signifi cantly higher than Prostodin group, 30 (11.9) ml (p <0.001). Conclusion: Intravaginal Misoprostol use gives better cervical dilatation when compared to intramuscular Prostodin.
Leave Your Message 24x7